6.300
−3,08%
2026-10-14
Fundamental Analysis
48 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +12.7% | +17.3% | 2 / 3 | +104.1% | -2.77 pp | -0.17 pp | +5.6% | 0.00 | 7.20 | 1.144 | +104,1% | 2,4 | +12,7% | 7.20 | 11.92 | −39,6% |
| Pts | 0 | 0 | 8 | 12 | 4 | 4 | 0 | 12 | 12 | |||||||
Valuation annotation:Price: 6.300 (close price on 2026-10-14)EPS (TTM): 875,5
Financial charts
1.Revenue & growth
VND bn1.144Q2/26
1.Revenue & growth
VND bn1.144Q2/26
2.Profit & growth
VND bn2,35Q2/26
3.Profit mix (Penman)
VND bn14,7Q2/26
4.Margins & cost structure
%5.3%Q2/26
5.Returns & cash cycle
% · days4.5%Q2/26
6.Earnings quality & cash
VND bn-4,60Q2/26
7.Asset structure
VND bn431Q2/26
8.Funding & debt health
VND bn · times431Q2/26
9.Revenue backlog
VND bn11,0Q2/26
10.Valuation
times · %7,2×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %190Q2/26
Adjusted EPS growth, latest quarter
12.7%
Average adjusted EPS growth, 3 quarters
17.3%
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26